ATAMIS LTD

Contract awards

• UKRI-5133 MRC LMB Microscope Servicing

  Awarded contractContract ends 31 Jul, 202821 monthsValue £683.88kSource Contracts Finder

  Repair and Maintenance Service for microscopes

  Awarded to Carl Zeiss Ltd

• Admin Test 0.1

  Awarded contractPublished 30 May, 2024Value £10.00kSource Contracts Finder

  Test 0.1

  Awarded to CAPGEMINI UK PLC

• Attend Anywhere Video Consultation

  Awarded contractPublished 19 Apr, 2024Value £82.65kSource Contracts Finder

  Attend Anywhere Video Consultation Services

  Awarded to ATTEND ANYWHERE PTY LTD

• Property Planning Consultancy

  Awarded contractContract ends 31 Mar, 20275 monthsValue £371.18kSource Contracts Finder

  Property Planning Consultancy

  Awarded to Matthew Allchurch Architects Limited t/a MAA Architects

• Property Planning Consultancy

  Awarded contractContract ends 31 Mar, 20275 monthsValue £144.00kSource Contracts Finder

  Property Planning Consultancy

  Awarded to Trilogy Land & New Homes

• Microsoft Licences

  Awarded contractPublished 11 Jan, 2024Value £128.49kSource Contracts Finder

  Microsoft Licence Subscription

  Awarded to TRUSTMARQUE SOLUTIONS LIMITED

• Carenotes- Right To Use- Licence

  Awarded contractContract ends 2 Aug, 203157 monthsValue £319.92kSource Contracts Finder

  To create Read/Write Access software for taking Carenotes.

  Awarded to ADVANCED BUSINESS SOFTWARE AND SOLUTIONS LIMITED

• Programme Director Services

  Awarded contractPublished 3 Oct, 2023Value £92.58kSource Contracts Finder

  To recruit an outsourced Programme Director on a contract basis to deliver the ADAPT Programme including the development of the FBC, Frontline Digitisation funding, and programme delivery.

  Awarded to HUNTER HEALTHCARE RESOURCING LIMITED

• NHS National Generic Pharmaceuticals Wave 14b

  Awarded contractPublished 15 Aug, 2023Source Contracts Finder archive

  Invitation to offer for NHS National Generic Pharmaceuticals Wave 14b Offer reference number: CM/PHG/22/5668 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 24 months with an option or options to extend (at the Authority's discretion) for a period or periods up to

  Awarded to Aspen Pharmacare UK Limited, Flexipharm Austrading Limited, Laboratorio Reig Jofre SA, Colonis Pharma Ltd, Consilient Health Ltd, hameln pharma ltd, Galvany Pharma Ltd, Piramal Critical care Limited, Martindale Pharma, Fresenius Kabi Limited, Amarox Limited, Sandoz Ltd, Lundbeck Limited, Pfizer Ltd, Stirling Anglian Pharmaceuticals Ltd, Lucane Pharma, GlaxoSmithKline UK Limited, Wockhardt UK Limited, Kent Pharma Ltd, Morningside Pharmaeuticals, Arcadia Pharma Ltd T/A Arcadia Medical, Thornton and Ross Ltd, Milpharm Ltd/aurobinbdo, Accord-UK Ltd, Bowmed Ibisqus Limited, Mylan, B. Braun Medical Limited, Thea Pharmaceuticals Limited, Neuraxpharm UK Ltd, Biocon, Esteve Pharmaceuticals Ltd, Manx Healthcare Ltd, CST Pharma Limited, Janssen-Cilag Ltd, P M Pharma, PARI, Otsuka Pharmaceuticals UK Limited, Ferring Pharmaceuticals Ltd, Teva UK Limited, Bristol Laboratories Limited, Dr.Reddy's Laboratories (UK) Limited, Selective Supplies Ltd., Day Lewis Medical Ltd, Bayer Plc, Sun Pharma UK Ltd, FLYNN PHARMA LTD, Glenmark Pharmaceuticals Europe Limited, MSN Laboratories Europe Limited, Aventis Pharma ltd t/a Sanofi, Chiesi Limited, Gerot Lannach UK Ltd, Lupin Healthcare (UK) Limited, medac Pharma LLP, Recordati Pharmaceuticals Ltd, Relonchem Ltd, Baxter Healthcare Ltd, Zentiva Pharma UK Ltd, Mercury Pharmaceuticals Limited, Macure Pharma ApS, AGB Pharma, Aspire Pharma Limited, Aguettant Ltd, Alturix, Beaumont Pharma Ltd, Panpharma UK Limited, Cipla, Roma Pharmaceuticals Limited, Roche Products Ltd, Ridge Pharma, MIP Pharma GmbH, Takeda UK Ltd, Novartis Pharmaceuticals UK Ltd, Norgine Pharmaceuticals Limited, ROVI Biotech Ltd, Bristol Myers Squibb, Perennial Pharma Ltd, Ascend Laboratories UK Ltd, Zista Pharma Ltd, Brown & Burk UK Ltd, Torbay Pharmaceuticals, Synchrony, Almirall, Tillomed Laboratories ltd, Seacross Pharmaceuticals Ltd, Syri Limited (T/A Thame Laboratories), RPH Pharmaceuticals AB, Tetris Pharma Lts, GH Pharma Ltd, Sintetica Ltd, GENNISIUM PHARMA, Phoenix Lab, Crescent Pharma Ltd, Kyowa Kirin Ltd, Typharm Ltd, Vantage Pharmaceuticals Ltd, Bausch + Lomb (Pharma), JCSH Pharma Ltd, Brancaster Pharma Ltd, Waymade PLC

• DCIQ - Datix Cloud

  Awarded contractContract ends 30 Jan, 202815 monthsValue £562.13kSource Contracts Finder

  Incident Reporting

  Awarded to SPECIALIST COMPUTER CENTRES PLC

• Fortigate Firewalls

  Awarded contractPublished 13 Jun, 2023Value £280.72kSource Contracts Finder

  FortiGate-1100E Hardware including 24x7 FortiCare and FortiGuard Unified Threat Protection (UTP)

  Awarded to INSIGHT DIRECT UK LTD

• North West Hospital Cisco Kit

  Awarded contractPublished 25 Apr, 2023Value £304.78kSource Contracts Finder

  North West Hospital Cisco Kit

  Awarded to CDW LIMITED

• Rostering Software Professional Services

  Awarded contractPublished 16 Sept, 2022Value £172.80kSource Contracts Finder archive

  This is a contract to support the National Vaccine Programme on a quick turnaround data feed that will be provided directly to the National Vaccine Operating Centre (NVOC) which will be used on an ongoing basis to provide visibility of rostered NHS staff. To achieve this data feed, NHSE/I will contract with the Supplie

  Awarded to Allocate Software Limited

• Contract Award Notice - Digital Health Intelligence Membership Subscription

  Awarded contractPublished 9 Aug, 2022Value £99.70kSource Contracts Finder archive

  Digital Health Intelligence Membership Subscription

  Awarded to DIGITAL HEALTH INTELLIGENCE LIMITED

• NHS National Generic Pharmaceuticals Wave 13

  Awarded contractPublished 22 Jul, 2022Source Contracts Finder archive

  Invitation to offer for NHS National Generic Pharmaceuticals Wave 13 Offer reference number: CM/PHG/17/5532 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 28 months, with an option or options to extend (at the Authority's sole discretion) for a period or periods

  Awarded to ATNAHS PHARMA UK LIMITED, CHIESI LIMITED, Correvio GmbH, FLYNN PHARMA LIMITED, FOCUS PHARMACEUTICALS LIMITED, GALEN LIMITED, Recordati Pharmaceuticals, TAKEDA UK LIMITED, TILLOMED LABORATORIES LIMITED, UPJOHN UK LIMITED, Waymade PLC, Alturix, Beaumont Pharma Ltd, Clydesdale Pharma ltd, Euro-Link Pharma Ltd, INTRAPHARM LABORATORIES LIMITED, IPCA LABORATORIES UK LIMITED, MEDLEY PHARMA LIMITED, MIBE PHARMA UK LTD, NECESSITY SUPPLIES LIMITED, NORTHUMBRIA PHARMA LTD, Noumed Life Sciences Limited, Oralieve UK Ltd, P M PHARMA LTD, PANPHARMA UK LIMITED, Phoenix Lab, SCIECURE PHARMA LIMITED, SINTETICA LIMITED, Sobi (Swedish Orphan Biovitrum Ltd), TETRIS PHARMA LTD, TRANSDERMAL LIMITED, VANTAGE PHARMACEUTICALS LTD, Pfizer Ltd, Merck Sharpe & Dohme (UK) Limited, Allergan, Medreich PLC, ennogen healthcare ltd, GlaxoSmithKline UK Limited, Syri Limited (T/A Thame Laboratories), hameln pharma ltd, medac Pharma LLP, Martindale Pharma, Rosemont Pharmaceuticals Limited, Mercury Pharmaceuticals Limited, Selective Supplies Ltd., Nexcape Pharmaceuticals Ltd., Consilient Health Ltd, Sandoz Ltd, Fresenius Kabi Limited, Glenmark Pharmaceuticals Europe Limited, Laboratorio Reig Jofre SA, Kent Pharma Ltd, Bowmed Ibisqus Limited, Kensington Pharma Ltd, Healthcare Pharma Ltd, Thornton and Ross Ltd, Mylan, Macleods Pharma UK Limited, Wockhardt UK Limited, Thea Pharmaceuticals Limited, Dr Falk Pharma UK Ltd, Desitin Pharma Ltd, Stragen UK Ltd, B. Braun Medical Limited, Torrent Pharma UK Ltd, Fontus Health Ltd, Aspire Pharma Limited, Teva UK Limited, Amarox Limited, AOP Orphan Ltd, Pierre Fabre Ltd, Macure Pharma ApS, Ranbaxy UK, Arcadia Pharma Ltd T/A Arcadia Medical, Derma UK, Zista Pharma Ltd, Dr.Reddy's Laboratories (UK) Limited, Aspen Pharmacare UK Limited, Manx Healthcare Ltd, Colonis Pharma Ltd, Roche Products Ltd, Waverley Pharma Europe Limited, Profile Pharma Ltd, Reckitt Benckiser, Zentiva Pharma UK Ltd, Baxter Healthcare Ltd, Organon Pharmaceuticals UK Ltd, Day Lewis Medical Ltd, LogixX Pharma Ltd, Lundbeck Limited, Napp Pharmaceuticals Ltd, Bayer Ltd, Recordati Rare Diseases UK Ltd, Morningside Pharmaeuticals, Dexcel Pharma Ltd, CST Pharma Limited, Cipla (EU) Ltd, Flexipharm Austrading Limited, Relonchem Ltd, LEO Pharma, Aguettant Ltd, Torbay Pharmaceuticals, RPH Pharmaceuticals AB, Drugsrus Ltd, Ferring Pharmaceuticals Ltd, Milpharm Ltd/aurobinbdo, PARI, Crescent Pharma Ltd, Roma Pharmaceuticals Limited, Kyowa Kirin Ltd, Brown & Burk UK Ltd, Seacross Pharmaceuticals Ltd, Lupin Healthcare (UK) Limited, Alliance Pharmaceuticals Limited, Bristol Laboratories Limited, Aristo Pharma Limited, Synchrony, Alissa Healthcare Research Limited, Altan Pharma Ltd, Lucane Pharma, Norgine Pharmaceuticals Limited, Neon Healthcare Ltd, Aventis Pharma ltd t/a Sanofi, MIP Pharma GmbH, Accord-UK Ltd, ACIUM LTD, Ascend Laboratories UK Ltd, Rivopharm UK Ltd, Strides Pharma Uk LTD, V Pharma, FERNDALE PHARMACEUTICALS LIMITED, TYPHARM LIMITED

• The Supply of Acquisition, Design and Build Services for Telecoms Mast Base Station Sites for the Emergency Services Mobile Communications Programme (ESMCP) and Shared Rural Network (SRN) - Teligent Ltd

  Awarded contractPublished 27 May, 2022Value £20.00mSource Contracts Finder archive

  UPDATE: The Daly International UK Ltd contract was novated to Teligent Ltd on 6th April 2022. Daly International has been appointed as one of two framework suppliers to provide Acquisition, Design and Build services for telecoms mast base station sites (including new build, upgrades, NTQ management or decommissioning

  Awarded to DALY INTERNATIONAL UK LTD, TELIGENT LTD

• The Supply of Acquisition, Design and Build Services for Telecoms Mast Base Station Sites for the Emergency Services Mobile Communications Programme (ESMCP) and Shared Rural Network (SRN) - WHP Telecoms

  Awarded contractPublished 27 May, 2022Value £20.00mSource Contracts Finder archive

  WHP Telecoms has been appointed as one of two framework suppliers to provide Acquisition, Design and Build services for telecoms mast base station sites (including new build, upgrades, NTQ management or decommissioning thereof). The Framework Agreement will comprise of two (2) Suppliers that will provide the ADB Servi

  Awarded to WHP TELECOMS LTD

• Vodafone PND PSN

  Awarded contractPublished 26 Apr, 2022Value £364.29kSource Contracts Finder archive

  Police National Database Vodafone PSN Connect Encrypt Additional information: Framework RM3808 Lot 1

  Awarded to VODAFONE LTD

• PND Cloud Gateway Client Access Service

  Awarded contractPublished 22 Apr, 2022Value £2.96mSource Contracts Finder archive

  Police National Database Cloud Gateway Client Access Service Additional information: G-Cloud 12 Framework Agreement (RM1557.12)

  Awarded to THALES UK LTD

• PND Core Gateway Service

  Awarded contractPublished 22 Apr, 2022Value £613.62kSource Contracts Finder archive

  Police National Database Core Gateway Service Additional information: G-Cloud 12 Framework Agreement RM1557.12

  Awarded to THALES UK LTD